Suchergebnisse - "Lopinavir"

PubPharm (1.799)

101

Comparison of demographic and clinical characteristics of hospitalized COVID-19 patients with severe/critical illness in the first wave versus the second wave

enthalten in: Journal of medical virology | 2022

von Sargin Altunok, E. | Satici, C. | Dinc, V. | +7

102

Comparing Outcomes of Two Antiviral Therapy Combinations among COVID-19 Patients

enthalten in: BioMed research international | 2022

von Mazaherpour, H. | Sofian, M. | Farahani, E. | +4

103

Mechanisms of COVID-19-induced kidney injury and current pharmacotherapies

enthalten in: Inflammation research : official journal of the European Histamine Research Society ... [et al. | 2022

von Faour, W. | Choaib, A. | Issa, E. | +7

104

Osteonecrosis of the humeral head in a human immunodeficiency virus-infected patient under tenofovir disoproxil fumarate-emtricitabine-lopinavir/ritonavir for 10 years : a case report

enthalten in: Journal of medical case reports | 2021

von Diallo, K. | Wembulua, B. | Aidara, M. | +2

105

Comparing the effectiveness of Atazanavir/Ritonavir/Dolutegravir/Hydroxychloroquine and Lopinavir/Ritonavir/Hydroxychloroquine treatment regimens in COVID-19 patients

enthalten in: Journal of medical virology | 2021

von Kalantari, S. | Fard, S. | Maleki, D. | +4

106

An open-label randomized controlled trial of the effect of lopinavir/ritonavir, lopinavir/ritonavir plus IFN-β-1a and hydroxychloroquine in hospitalized patients with COVID-19

enthalten in: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases | 2021

von Ader, F. | Peiffer-Smadja, N. | Poissy, J. | +56

CommentIn: Clin Microbiol Infect. 2021 Dec;27(12):1716-1717. - PMID 34508887

107

Combining subsidiary and synchronous approaches for concurrent spectrofluorimetric assurance of lopinavir and ritonavir in tablets utilized in convention for treatment of coronavirus infection (COVID-19) and biological fluids

enthalten in: Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy | 2021

von Salem, H. | Samir, E. | Abdelaziz, A. | +4

108

A multi-centre, randomized, double-blind, placebo-controlled clinical trial of the efficacy and safety of chloroquine phosphate, hydroxychloroquine sulphate and lopinavir/ritonavir for the treatment of COVID-19 in Lagos State : study protocol for a randomized controlled trial

enthalten in: Trials | 2021

von Abayomi, A. | Osibogun, A. | Ezechi, O. | +8

109

Comparative Bioavailability of Two Formulations of Biopharmaceutical Classification System (BCS) Class IV Drugs : A Case Study of Lopinavir/Ritonavir

enthalten in: Journal of pharmaceutical sciences | 2021

von Saeed, A. | Schmidt, J. | Munasinghe, W. | +4

110

Pharmacoepidemiological research of COVID-19 in the Russian Federation EGIDA-2020

enthalten in: Terapevticheskii arkhiv | 2021

von Pshenichnaya, N. | Kareva, E. | Leneva, I. | +15